Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

MYC Targets Scores Are Associated with Cancer Aggressiveness and Poor Survival in ER-Positive Primary and Metastatic Breast Cancer

International Journal of Molecular Sciences(2020)10.3390/ijms21218127Source: DataRank Database

MYC Targets Scores Are Associated with Cancer Aggressiveness and Poor Survival in ER-Positive Primary and Metastatic Breast Cancer is a research paper published in International Journal of Molecular Sciences (2020). On theSindex it has a DataRank of 0. It has been cited 134 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access134 citations

Download PDF

Cite:

Linked data & code

geo

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 5.40)OA: goldTopics (65)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Masanori Oshi ORCID,Itaru Endo ORCID,Kazuaki Takabe ORCID,Amy K. Schulze

Live enrichment

PubMed:33143224 PMC:PMC7663719 OpenAlex:https://openalex.org/W3097629227

National Institutes of Health

Grant: R01CA160688

National Cancer Institute, USA

Grant: P30-CA016056

National Institutes of Health

Grant: 5P30CA016056-40

Roswell Park Cancer Institute Cancer Center Support Grant

National Institutes of Health

Grant: 5R01CA160688-03

Sphingosine-1-phosphate in breast cancer progression and lymphangiogenesis

FWCI

5.40

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/1422-0067/21/21/8127/pdf?version=1604062971

publisherhttps://www.mdpi.com/1422-0067/21/21/8127/pdf?version=1604062971

publisherhttps://www.mdpi.com/1422-0067/21/21/8127/pdf

journalhttps://doi.org/10.3390/ijms21218127

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33143224

Fields of Study

Cancer Immunotherapy and BiomarkersFerroptosis and cancer prognosisCancer Genomics and Diagnostics0301 basic medicine0303 health sciences03 medical and health sciencesBiomarkers, TumorBreast NeoplasmsFemaleFollow-Up StudiesGene Expression Regulation, NeoplasticHumansNeoplasm MetastasisPrognosisProto-Oncogene Proteins c-mycErb-b2 Receptor Tyrosine KinasesReceptors, EstrogenReceptors, ProgesteroneRetrospective StudiesSurvival Rate

MeSH Terms

Breast NeoplasmsFemaleFollow-Up StudiesHumansNeoplasm MetastasisPrognosisReceptors, EstrogenReceptors, ProgesteroneRetrospective StudiesBiomarkers, TumorGene Expression Regulation, NeoplasticSurvival RateProto-Oncogene Proteins c-mycReceptor, ErbB-2Erb-b2 Receptor Tyrosine Kinases

Keywords

Breast cancerMedicineOncologyInternal medicineCancerCohortMetastatic breast cancerPrimary tumorImmune systemCancer researchMetastasisImmunologyMYCBiomarkerTumor Gene ExpressionBreast NeoplasmsPrognosisErb-b2 Receptor Tyrosine KinasesArticleGene Expression Regulation, NeoplasticProto-Oncogene Proteins c-mycSurvival RateReceptors, EstrogenBiomarkers, TumorHumansFemaleNeoplasm MetastasisReceptors, ProgesteroneFollow-Up StudiesRetrospective Studies

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

MYC Targets Scores Are Associated with Cancer Aggressiveness and Poor Survival in ER-Positive Primary and Metastatic Breast Cancer

FAIR Checklist

Authors (4)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)